Automatically clustered newsroom coverage around one of the most active themes in the intellectual property ecosystem.
IIPLA reviews the patents implications of Patents, CCIA Encourages Supreme Court, Hear Patent Case Washington, with practical notes for USA IP teams monitoring risk, enforcement, licensing, and portfolio strategy.
The U.S. Supreme Court has ruled in favor of Hikma Pharmaceuticals in a patent infringement case brought by Amarin. This ruling resolves a significant dispute over patent rights and market competition between the two pharmaceutical companies.
The Supreme Court’s upcoming 2024-2025 term includes fifteen pending patent cases that collectively question longstanding Federal Circuit procedures and substantive patent law principles. Central among these are five petitions challenging the Federal Circuit’s frequent use of Rule 36 summary affirmances for lack of re…
Subscribe to receive daily and weekly newsroom coverage aligned to this trend cluster and adjacent IP developments.